UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

Pearl Index study with levonorgestrel-releasing intravaginal rings: using pharmacokinetic results to investigate treatment compliance as a potential contributor for contraceptive failure

Human reproduction (Oxford), 2020-11, Vol.35 (11), p.2515-2523

2020

Link zum Volltext

Verfügbarkeit prüfen

Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial

Human reproduction (Oxford), 2011-10, Vol.26 (10), p.2698-2708

2011

Link zum Volltext

Verfügbarkeit prüfen

Intramuscular Testosterone Undecanoate: Pharmacokinetic Aspects of a Novel Testosterone Formulation during Long-Term Treatment of Men with Hypogonadism

The journal of clinical endocrinology and metabolism, 2004-11, Vol.89 (11), p.5429-5434

2004

Link zum Volltext

Verfügbarkeit prüfen

Effect of four different oral contraceptives on various sex hormones and serum-binding globulins

Contraception (Stoneham), 2003, Vol.67 (1), p.25-32

2003

Link zum Volltext

Verfügbarkeit prüfen

Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: Results from the multicentre, randomised, double-blind, active-controlled HARMONY II study

Journal of obstetrics and gynaecology, 2013-08, Vol.33 (6), p.591-596

2013

Link zum Volltext

Verfügbarkeit prüfen

Effects of combined oral contraceptive ethinylestradiol (30 microg) and dienogest (2 mg) on carbohydrate metabolism during 1 year of conventional or extended-cycle use

Hormone and metabolic research, 2010-05, Vol.42 (5), p.358

2010

Link zum Volltext

Verfügbarkeit prüfen

O319 A novel oral contraceptive comprising estradiol valerate/dienogest for the treatment of heavy and/or prolonged menstrual bleeding without organic cause: a double-blind, randomised, placebo-controlled trial

International journal of gynecology and obstetrics, 2009-10, Vol.107 (S2), p.S183-S184

2009

Link zum Volltext

Verfügbarkeit prüfen

Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters

Contraception (Stoneham), 2003-05, Vol.67 (5), p.361-366

2003

Link zum Volltext

Verfügbarkeit prüfen

A multicenter, double-blind, randomized, placebo-controlled study of oral estradiol valerate/dienogest for the treatment of heavy and/or prolonged menstrual bleeding

Fertility and sterility, 2009, Vol.92 (3), p.S32-S32

2009

Link zum Volltext

Verfügbarkeit prüfen

Comparison of a new long-acting testosterone undecanoate formulation vs testosterone enanthate for intramuscular androgen therapy in male hypogonadism

Journal of endocrinological investigation, 2008-08, Vol.31 (8), p.718-723

2008

Link zum Volltext

Verfügbarkeit prüfen

Effective Treatment of Heavy Menstrual Bleeding With Estradiol Valerate and Dienogest: A Randomized Controlled Trial

Obstetrics and gynecology (New York. 1953), 2011-04, Vol.117 (4), p.777-787

2011

Link zum Volltext

Verfügbarkeit prüfen

A four-year efficacy and safety study of the long-acting parenteral testosterone undecanoate

The aging male, 2007-09, Vol.10 (3), p.155-158

2007

Link zum Volltext

Verfügbarkeit prüfen

Effect of dienogest-containing oral contraceptives on lipid metabolism

Contraception (Stoneham), 2002-03, Vol.65 (3), p.223-229

2002

Link zum Volltext

Verfügbarkeit prüfen

Influence of a continuous combined HRT (2 mg estradiol valerate and 2 mg dienogest) on postmenopausal depression

Climacteric : the journal of the International Menopause Society, 2004-09, Vol.7 (3), p.301-311

2004

Link zum Volltext

Verfügbarkeit prüfen

Effect of a Low-Dose Contraceptive Patch on Efficacy, Bleeding Pattern, and Safety: A 1-Year, Multicenter, Open-Label, Uncontrolled Study

Reproductive sciences (Thousand Oaks, Calif.), 2014-12, Vol.21 (12), p.1518-1525

2014

Link zum Volltext

Verfügbarkeit prüfen

Influence of Dienogest on Ovulation in Young Fertile Women

Clinical drug investigation, 1999, Vol.18 (4), p.271-278

1999

Link zum Volltext

Verfügbarkeit prüfen

Hormone withdrawal-associated symptoms: Comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimate

The European journal of contraception & reproductive health care, 2013-08, Vol.18 (4), p.274-283

2013

Link zum Volltext

Verfügbarkeit prüfen

Continuous-combined treatment of the menopause with combinations of oestradiol valerate and dienogest — a dose-ranging study

Maturitas, 2000-06, Vol.35 (3), p.253-261

2000

Link zum Volltext

Verfügbarkeit prüfen

Can oral contraceptive steroids influence the elimination of nifedipine and its primary pryidine metabolite in humans?

European journal of clinical pharmacology, 1998-11, Vol.54 (9-10), p.729-734

1998

Link zum Volltext

Verfügbarkeit prüfen

A comparative study of the effects of two oral contraceptives containing dienogest or desogestrel on the human immune system

Gynecological endocrinology, 2000, Vol.14 (1), p.15-24

2000

Link zum Volltext

Verfügbarkeit prüfen

Modulation of ovarian function by an oral contraceptive containing 30 μg ethinyl estradiol in combination with 2.00 mg dienogest

Contraception (Stoneham), 1997-09, Vol.56 (3), p.185-191

1997

Link zum Volltext

Verfügbarkeit prüfen

Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use

Contraception (Stoneham), 2008-06, Vol.77 (6), p.420-425

2008

Link zum Volltext

Verfügbarkeit prüfen

Hormone withdrawal-associated symptoms (headache and pelvic pain) in women taking combined oral contraceptives: Comparison of oestradiol valerate/dienogest versus ethinylestradiol/levonorgestrel

The European journal of contraception & reproductive health care, 2012-06, Vol.17, p.S100

2012

Link zum Volltext

Verfügbarkeit prüfen

Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 μg ethinyl estradiol and 2.00 mg dienogest on the hemostatic system

Contraception (Stoneham), 1997-08, Vol.56 (2), p.67-75

1997

Link zum Volltext

Verfügbarkeit prüfen

Multizentrische Studie zu kontrazeptiver Sicherheit, Zyklusbeeinflussung und Verträglichkeit von MP 2000 Mikropille — Ein Zwischenbericht

Dienogest, 2021, p.203-212

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(38)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Humans
(32)
Life Sciences & Biomedicine
(32)
Adult
(23)
Female
(23)
Biological And Medical Sciences
(19)
Medical Sciences
(18)
Nandrolone - Analogs & Derivatives
(16)
Obstetrics & Gynecology
(15)
Dienogest
(12)
Adolescent
(11)
Male
(11)
Estradiol - Analogs & Derivatives
(10)
Nandrolone - Administration & Dosage
(10)
Double-Blind Method
(9)
Pharmacology. Drug Treatments
(9)
Birth Control
(8)
Endocrinology & Metabolism
(8)
Estradiol - Administration & Dosage
(7)
Ethinyl Estradiol - Administration & Dosage
(7)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Pearl Index study with levonorgestrel-releasing intravaginal rings: using pharmacokinetic results to investigate treatment compliance as a potential contributor for contraceptive failure

Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial

Intramuscular Testosterone Undecanoate: Pharmacokinetic Aspects of a Novel Testosterone Formulation during Long-Term Treatment of Men with Hypogonadism

Effect of four different oral contraceptives on various sex hormones and serum-binding globulins

Effects of a combined oral contraceptive containing oestradiol valerate/dienogest on hormone withdrawal-associated symptoms: Results from the multicentre, randomised, double-blind, active-controlled HARMONY II study

Effects of combined oral contraceptive ethinylestradiol (30 microg) and dienogest (2 mg) on carbohydrate metabolism during 1 year of conventional or extended-cycle use

O319 A novel oral contraceptive comprising estradiol valerate/dienogest for the treatment of heavy and/or prolonged menstrual bleeding without organic cause: a double-blind, randomised, placebo-controlled trial

Effect of four oral contraceptives on thyroid hormones, adrenal and blood pressure parameters

A multicenter, double-blind, randomized, placebo-controlled study of oral estradiol valerate/dienogest for the treatment of heavy and/or prolonged menstrual bleeding

Comparison of a new long-acting testosterone undecanoate formulation vs testosterone enanthate for intramuscular androgen therapy in male hypogonadism

Effective Treatment of Heavy Menstrual Bleeding With Estradiol Valerate and Dienogest: A Randomized Controlled Trial

A four-year efficacy and safety study of the long-acting parenteral testosterone undecanoate

Effect of dienogest-containing oral contraceptives on lipid metabolism

Influence of a continuous combined HRT (2 mg estradiol valerate and 2 mg dienogest) on postmenopausal depression

Effect of a Low-Dose Contraceptive Patch on Efficacy, Bleeding Pattern, and Safety: A 1-Year, Multicenter, Open-Label, Uncontrolled Study

Influence of Dienogest on Ovulation in Young Fertile Women

Hormone withdrawal-associated symptoms: Comparison of oestradiol valerate/dienogest versus ethinylestradiol/norgestimate

Continuous-combined treatment of the menopause with combinations of oestradiol valerate and dienogest — a dose-ranging study

Can oral contraceptive steroids influence the elimination of nifedipine and its primary pryidine metabolite in humans?

A comparative study of the effects of two oral contraceptives containing dienogest or desogestrel on the human immune system

Modulation of ovarian function by an oral contraceptive containing 30 μg ethinyl estradiol in combination with 2.00 mg dienogest

Effects of an oral contraceptive containing 30 mcg ethinyl estradiol and 2 mg dienogest on thyroid hormones and androgen parameters: conventional vs. extended-cycle use

Hormone withdrawal-associated symptoms (headache and pelvic pain) in women taking combined oral contraceptives: Comparison of oestradiol valerate/dienogest versus ethinylestradiol/levonorgestrel

Double-blind, randomized, placebo controlled study on the effects of the monophasic oral contraceptive containing 30 μg ethinyl estradiol and 2.00 mg dienogest on the hemostatic system

Multizentrische Studie zu kontrazeptiver Sicherheit, Zyklusbeeinflussung und Verträglichkeit von MP 2000 Mikropille — Ein Zwischenbericht

Suchergebnisse filtern